Everest Medicines (HKEX 1952.HK) announced that it has entered into an exclusive licensing and collaboration agreement with Travere Therapeutics, Inc.
Detailed price information for Travere Therapeutics Inc (TVTX-Q) from The Globe and Mail including charting and trades.
Detailed price information for Travere Therapeutics Inc (TVTX-Q) from The Globe and Mail including charting and trades.
A series of major studies has shown that finerenone preserves kidney function, reduces cardiovascular risk, and improves survival across a much broader range of patients with chronic kidney disease ...
GlobalData on MSN
Otsuka’s Voyxact preserves kidney function at 12 months
Otsuka’s Voyxact was granted accelerated approval from the FDA in November 2025 based on nine-month data.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results